The Global Acute
Otitis Media Treatment Market, By Drug Type (Antibiotics, Nonsteroidal
anti-Inflammatory Drug, Analgesic, and Anaesthetic), By Formulation (Oral and
Topical), By Distribution Channel (Hospitals, Retail Pharmacies, and Online
Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific,
the Middle East, and Africa) was valued at US$ 2,043.3 million in 2016 and is
projected to exhibit a CAGR of 5.1% over the forecast period (2017 – 2025).
Increasing prevalence of acute
otitis media is expected to be a major factor in growth of acute otitis media
treatment market. According to an article published in PLOS ONE Journal in
2012, acute otitis media incidence rate is about 10.9% and around 709 million
people suffer from this diseases each year. Of these, children under the age of
5 account for around 51%. Increasing prevalence of acute otitis media among
children is expected to lead to increasing demand for treatment.
Acute otitis media (AOM) is a
type of ear infection in which air-filled space behind the eardrum (the middle
ear) is infected and causes pain and general symptoms of illness such as fever,
irritability and problem in sleeping. AOM is a most common ear infections among
children as the Eustachian tube is shorter as compared to adults, which makes
it more accessible to bacteria and viruses. Bacteria such as Streptococcus
pneumoniae (strep) and Hemophilus influenzae (H. flu) account for around 85% of
cases of AOM and viruses account for only 15% of these cases.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1333
Browse 36 Market Data Tables and
42 Figures spread through 178 Pages and in-depth TOC on Acute Otitis Media
Treatment Market by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory
drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End
User (Hospitals, Retail pharmacies, and Online pharmacies) and Region (North
America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) -
Global Forecast to 2025.
Key players in the acute otitis
media treatment market are focusing on launching multiple products.
Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC launched OTOVEL
(ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) and the solution
indicated for the treatment of acute otitis media. Increasing product approvals
is another factor expected to aid in growth of the market. For instance, in
2017, Committee for Medicinal Products for Human Use (CHMP) of the European
Medicines Agency (EMA) issued a positive opinion on GlaxoSmithKline plc. new
four-dose vial of Synflorix pneumococcal vaccine indicated for active immunisation
against acute otitis media. In 2013, Pfizer Inc. received European approval to
expand use of its Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine)
for adults aged 18 to 49 years for the prevention of invasive disease,
pneumonia and acute otitis media caused by Streptococcus pneumonia. In 2015,
Otonomy, Inc. received U.S. Food and Drug Administration (FDA) approval for its
OTIPRIO (ciprofloxacin otic suspension) used in the treatment of AOM.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/acute-otitis-media-treatment-market-1333
Key Takeaways of the Acute Otitis
Media Treatment Market:
The global acute otitis media
treatment market is expected to exhibit a CAGR of 5.1% over the forecast period
(2017–2025), owing to increasing approvals by regulatory bodies to innovative
products for treatment of AOM.
North America was the dominant
region in the market and is expected to continue its dominance over the
forecast period (2017–2025). This is owing to increasing prevalence of acute
otitis media and launches of novel drugs for the treatment of acute otitis
media in the region.
Key players are focusing on
expanding its market presence by launching novel drugs and receiving marketing
approvals of their new products in key geographies
Major players operating in the
acute otitis media treatment market include Pfizer, Inc., Eli Lilly and
Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG,
Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1333
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment